[What is the prognosis of chronic immune thrombocytopenia?]

M L Calleja Gero1, J Sevilla, L Madero

  • 1Servicio de Pediatría, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Insights

Most children with chronic immune thrombocytopenia (ITP) achieve remission without treatment. Splenectomy offers good results, but spontaneous recovery is common, suggesting delayed intervention for chronic ITP.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Clinical Medicine

Context:

  • Investigated pediatric chronic immune thrombocytopenia (ITP) cases at Hospital Infantil Universitario Niño Jesús (HIUNJ) from 2003-2008.
  • Retrospective analysis of 42 children diagnosed with chronic ITP from a cohort of 288 patients with purpura and other hemorrhagic illnesses.

Purpose:

  • To analyze the characteristics of children with chronic ITP.
  • To evaluate the prognostic significance of clinical variables (age, gender, initial platelet count, treatment) on ITP outcomes.

Summary:

  • Nearly 60% of children with chronic ITP achieved remission without specific treatment, with 23.8% achieving remission post-splenectomy.
  • Spontaneous remission occurred in approximately 20% of patients within 6-12 months; clinical variables did not predict disease outcome.
  • The term 'chronic ITP' should be reserved for cases lasting over one year due to the high rate of spontaneous remission.

Impact:

  • Findings suggest delaying splenectomy in pediatric chronic ITP due to high spontaneous recovery rates and generally benign outcomes.
  • Highlights the importance of reconsidering the definition of chronic ITP based on remission timelines.
  • Provides insights into the natural history and management strategies for childhood chronic immune thrombocytopenia.
Abstract

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...